2025-10-22T17:12:59+00:00 2024-12-31 346565596 ERNST & YOUNG US LLP 155 N WACKER DRIVE CHICAGO IL 60606 990 2024-01-01 366134600 College of American Pathologists Foundation COLL 8478327000 325 WAUKEGAN ROAD NORTHFIELD IL 600932760 Eva M Wojcik President 8478327000 2025-10-22 true Jess Wagener P01622613 3128792000 2025-10-22 2024 2025-03-06 01:10:19Z Eva M Wojcik 325 WAUKEGAN ROAD NORTHFIELD IL 600932760 1697972 false X WWW. FOUNDATION.CAP.ORG X 1963 IL CHAMPION HUMANITARIAN & PATIENT-CENTERED ROLES FOR PATHOLOGISTS. CONNECT THOSE IN NEED TO THE SPECIALIZED, LIFE SAVINGS SKILLS OF PATHOLOGISTS. CONFER TRAINING & AWARDS TO RESIDENTS. 18 17 0 425 0 816202 934424 0 0 9741 162684 121671 41134 947614 1138242 237854 200110 0 0 0 0 0 0 162546 871565 864358 1109419 1064468 -161805 73774 3094985 3260071 327031 326365 2767954 2933706 SEE SCHEDULE O false false 782288 200110 0 THE FOUNDATION CHAMPIONS PATIENT-CENTERED AND HUMANITARIAN ROLES FOR PATHOLOGISTS STRIVING TO CONNECT PEOPLE, ESPECIALLY THOSE IN NEED, TO THE SPECIALIZED, LIFE-SAVING SKILLS OF PATHOLOGISTS. SEE, TEST & TREAT IS THE FOUNDATION'S FLAGSHIP ENDEAVOR. IT IS A FREE, PATHOLOGIST-LED CERVICAL AND BREAST CANCER-SCREENING PROGRAM OFFERED TO VULNERABLE WOMEN THROUGHOUT THE U.S. THE FOUNDATION REGARDS SEE, TEST & TREAT AS A MODEL PROGRAM TO SPUR ENGAGEMENT, REDUCE HEALTH DISPARITIES, AND IMPROVE HEALTH OUTCOMES IN MEDICALLY UNDERSERVED COMMUNITIES. THE FOUNDATION ALSO CONFERS EDUCATIONAL TRAINING AND LEADERSHIP AWARDS TO PATHOLOGY RESIDENTS TO INCREASE THE SPECIALTY'S IMPACT IN HEALTHCARE. THE CAP FOUNDATION'S REACH EXTENDS FAR BEYOUND U.S. BOARDERS. THROUGH OUR GLOABAL PATHOLOGY AWARD AND EDUCATIONAL PROGRAMS. WE'VE RECEIVED APPLICATIONS AND SUPPORTED AWARDEES FROM COUNTRIES AROUND THE WORLD. THIS GROWING INTERNATIONAL NETWORK REFLECTS OUR COMMITMENT TO ADVANCING PATHOLOGY, EXPANDING ACCESS TO CARE, AND EMPOWERING THE NEXT GENERATION OF PATHOLOGISTS. IN 2024 17 COUNTRIES WERE REACHED 37 GRANTS OR AWARDS WERE DISTRIBUTED. SEE, TEST & TREAT IS A LIFE SAVING PROGRAM THAT PROVIDES FREE CANCER SCREENING AND HELATH EDUCATION TO MEDICALLY UNDERSERVED COMMUNITIES, DELIVERING SAME-DAY RESULTS AND FOLLOW-UP CARE. LED BY VOLUNTEER PATHOLOGISTS AND SUPPORTED BY LOCAL HEALTH CARE TEAMS, THE PROGRAM REMOVES BARRIERS TO CARE AND EMPOWERS PATIENTS WITH CRITICAL KNOWLEDGE ABOUT THEIR HEALTH. IN 2024, 12 PROGRAMS WERE HOSTED ACROSS THE US, 600 UNINSURED AND UNDERINSURED WOMEN WERE SCREENED, 112 WERE CONNECTED TO ADDITIONAL FOLLOW UP CARE. THE CAP FOUNDATION'S GRANTS AND AWARDS SUPPORT THE NEXT GENERATION OF PATHOLOGISTS THROUGH FUNDING FOR LEADERSHIP DEVELOPMENT, GLOBAL HEALTH EXPERIENCES AND ADVANCED ACCESS TO EDUCATION AND STRENGTHEN THE FUTURE OF THE PATHOLOGY PROFESSION. IN 2024, 30 GRANTS AND AWARDS WERE GIVEN DOMESTICALLY, 30 STUDENTS, RESIDENTS AND FELLOWS WERE AWARDED. 782288 true true false false false false false false false true true false false false false false true false false false true true true false true false false true true true false false false false false false false false false false false false false false false true false false true false true 8 0 true 0 false false false false false true true false false false false false false X 18 17 false false false false false false false true true false false false true true true true true true false false false false IL X Akshay Patel 8478327597 325 WAUKEGAN ROAD NORTHFIELD IL 600932760 BHARATI S JHAVERI MD FCAP VICE-PRESIDENT 6.0 0.0 X X 0 0 0 EVA M WOJCIK MD FCAP PRESIDENT 9.0 0.0 X X 0 0 0 NICHOLAS T SERAFY JR SECRETARY-TREASURER (THRU 10/2024) 6.0 0.0 X X 0 0 0 TIMOTHY ALLEN MD JD FCAP SECRECTRAY-TRESURER 6.0 0.0 X X 0 0 0 EARLE COLLUM DIRECTOR (LIAISON) (THRU 10/2024) 4.0 0.0 X 0 0 0 GERALD R HANSON MD FCAP DIRECTOR 4.0 0.0 X 0 0 0 HAFSA NEBBACHE DIRECTOR (JUNIOR MEMBER, start 10/2024) 4.0 0.0 X 0 0 0 JAMES ORHEIM DIRECTOR (start 1/2024, THRU12/2024) 4.0 0.0 X 0 0 0 JOANNA L CONANT MD FCAP DIRECTOR 4.0 0.0 X 0 0 0 KALISHA HILL MD DIRECTOR (LIASION) 4.0 0.0 X 0 0 0 KAREN MUDD MA DIRECTOR 4.0 0.0 X 0 0 0 KATHRYN KNIGHT MD FCAP DIRECTOR 4.0 0.0 X 0 0 0 MARVIN KOGAN DIRECTOR 4.0 0.0 X 0 0 0 MASA PERIC DIRECTOR (JUNIOR MEMBER, THRU 10/2024) 4.0 0.0 X 0 0 0 MEGHA JOSHI MD DIRECTOR 4.0 0.0 X 0 0 0 MICHAEL FRASER CAP CEO DIRECTOR (Start 03/2024) 1.0 39.0 X 0 561898 3520 REBECCA JOHNSON MD DIRECTOR (LIAISON) (start 10/2024) 4.0 0.0 X 0 0 0 SARA HERBEK ESQ DIRECTOR 4.0 0.0 X 0 0 0 STEPHEN R MYERS CAP CEO DIRECTOR (THRU 03/2024) 1.0 39.0 X 0 573046 38149 SWIKRITY BASKOTA MD DIRECTOR 4.0 0.0 X 0 0 0 TABARI BAKER PhD DIRECTOR 4.0 0.0 X 0 0 0 TERRENCE SHIRLEY MPH DIRECTOR 4.0 0.0 X 0 0 0 THERESA ROHR-KIRCHGRABER MD FCAP DIRECTOR 4.0 0.0 X 0 0 0 MAYA OGDEN EXECUTIVE DIRECTOR CAP FOUNDATION 40.0 0.0 X 0 197188 45630 JULIA RANKENBURG PROGRAM DEVELOPMENT MANAGER 40.0 0.0 X 0 137036 44744 0 1469168 132043 0 true true false 0 0 0 11594 500000 0 422830 361 934424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 158433 0 0 158433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 498440 494189 4251 0 4251 0 0 4251 96131 11594 65541 30590 0 30590 0 0 0 0 0 0 0 0 0 0 0 0 ADMINISTRATIVE FEES 900099 10000 10000 RETURN OF GRANT AWARDS 900099 544 544 0 0 0 0 0 0 0 0 10544 1138242 0 0 203818 121588 121588 56774 56774 21748 21748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12000 0 12000 0 0 0 0 0 0 5910 1929 3981 37943 15366 4987 17590 0 0 0 0 5542 1302 811 3429 16968 0 16968 0 0 0 0 0 10250 0 10250 0 61597 18677 23647 19273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PURCHASED SERVICES 733694 540040 71487 122167 MISCELLANEOUS FEES 3115 3000 115 SUBSCRIPTIONS 1067 902 165 OUTSIDE PRINTING 664 462 202 -24392 500 -24979 87 1064468 782288 119634 162546 187400 148628 0 0 455668 235770 0 0 0 0 0 0 0 0 0 0 2500 2500 33462 33462 0 0 2417037 2845734 0 0 0 0 32380 27439 3094985 3260071 266801 277790 60230 48575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 327031 326365 X 1925985 2107912 841969 825794 0 0 0 2767954 2933706 3094985 3260071 73774 91978 0 0 0 0 X false true true false X 799804 2590633 920027 816202 934424 6061090 0 0 0 0 0 0 0 0 0 0 0 0 799804 2590633 920027 816202 934424 6061090 2990965 3070125 75745 137967 85067 94637 158433 551849 0 0 0 0 0 0 39935 52535 26752 72648 10544 202414 6815353 234245 0.45047 0.48658 X Schedule A, Part II, Line 10 Other Income DESCRIPTION - ADMINISTRATIVE FEES, COLUMN A - 2000.0, COLUMN B - 35500.0, COLUMN C - 18333.0, COLUMN D - 37648.0, COLUMN E - 10000.0, COLUMN F - 103481.0; DESCRIPTION - RETURN OF GRANTS AWARDED, COLUMN A - 37935.0, COLUMN B - 17035.0, COLUMN C - 8419.0, COLUMN D - 35000.0, COLUMN E - 544.0, COLUMN F - 98933.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 841969 416271 0 199567 229879 3000 825794 966701 191870 0 200205 113397 3000 841969 1317493 180906 -32698 308556 187112 3332 966701 610277 1095341 13832 188092 211365 2500 1317493 1372766 -332917 50433 145882 332123 2000 610277 0.0 0.0 1.0 true false 33462 33462 0 0 1495612 91978 206305 0 0 298283 1197329 5910 -64997 -59087 1138242 1329860 206305 0 0 0 206305 1123555 5910 -64997 -59087 1064468 Schedule D, Part V, Line 4 Intended uses of endowment funds INTENDED USE OF ENDOWMENT FUNDS THE FUND WAS ESTABLISHED FOR A VARIETY OF PURPOSES WHICH INCLUDES PROGRAM COSTS, GRANTS, AND SIMILAR COSTS ASSOCIATED WITH THE NON-PROFIT ORGANIZATION'S TAX EXEMPT PURPOSES. Schedule D, Part XI, Line 4(b) Other revenues in form 990 not in audited financial statements Return of unused award - 544 FUNDRAISING EXPENSES - Outside Vendor - -64500 FUNDRAISING EXPENSES - Credit Card Fees - -1041 Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statements Return of unused award - 544 FUNDRAISING EXPENSES - Outside Vendor - -64500 FUNDRAISING EXPENSES - Credit Card Fees - -1041 true Sub-Saharan Africa 0 0 Grantmaking 12500 South Asia 0 0 Grantmaking 9123 Europe (Including Iceland and Greenland) 0 0 Conference Travel 125 0 0 0 0 0 0 21748 0 21748 Sub-Saharan Africa SEE PART V 5000 WIRE Sub-Saharan Africa SEE PART V 7500 WIRE South Asia SEE PART V 9123 WIRE 3 0 TRAVEL AWARD Europe (Including Iceland and Greenland) 1 125 WIRE false false false false false false Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds To activate funding the institution must submit a tax form before the first half of funding is sent. A payment schedule is included in the award letter detailing due dates for required reports. The second half of payment is sent to the organization once all the requirements have been met. Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements SUB-SAHARAN AFRICA-Accrual Schedule F, Part II, Line 1 Method used to account for expenditures on org's financial statements SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual Schedule F, Part III Method used to account for expenditures on org's financial statements EUROPE (INCLUDING ICELAND AND GREENLAND) -Accrual Schedule F, Part V PART II, PURPOSE OF GRANTS In an effort to improve global health and the science and expansion of pathology and pathology services, the Global Pathology Development Grant from the College of American Pathologists Foundation offers funding, up to $10,000.00 USD, to support impactful, sustainable, and accretive global (international) projects that develop, expand, and sustain, the delivery of pathology services through education/training, patient care, laboratory quality, or enhanced technology and laboratory diagnostics. THE CAP FOUNDATION ANNUAL EVENT 107725 11594 96131 0 0 12000 35350 17150 1041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 107725 11594 96131 0 0 12000 35350 17150 1041 65541 30590 Schedule G, Part II FUNDRAISING EVENT IN 2024 THE FOUNDATION HELD ONE FUNDRAISING EVENT AT THE CAP FOUNDATION ANNUAL EVENT. true Friends of Kijabe 2404 Rock Creek D Charlotte NC 28226 475469826 501(c)(3) 9675 In an effort to improve global health and the science and expansion of pathology and pathology services, the Global Pathology Development Grant from the College of American Pathologists Foundation offers funding, up to $10,000.00 USD, to support impactful, sustainable, and accretive global (international) projects that develop, expand, and sustain, the delivery of pathology services through education/training, patient care, laboratory quality, or enhanced technology and laboratory diagnostics. University of Mississippi Foundation 2500 North State Street Jackson MS 39216 237310293 501(c)(3) 14904 CANCER SCREENING White Plains Hospital Medical Center 41 East Post Road White Plains NY 10601 131740130 501(c)(3) 8000 CANCER SCREENING St Marys Medical Center Foundation 2900 1st Ave Huntington VA 25702 141887211 501(c)(3) 11250 CANCER SCREENING BSW Irving Foundation 1901 N MacArthur Blvd Irving TX 75061 751570933 501(c)(3) 13175 CANCER SCREENING CHA Foundation 230 Highland Ave Somerville MA 02143 010676306 501(c)(3) 13284 CANCER SCREENING The Foundation for University Hospital (Rutgers) 150 Bergen Street Room D209C Newark NJ 07101 471686351 501(c)(3) 14300 CANCER SCREENING Liberty-Dayton Regional Medical Center 1353 Travis Street Liberty TX 77575 202797853 STATE GOV'T 8000 CANCER SCREENING Loyola Medicine Office of Philanthropy 2160 S First Avenue Maywood IL 60153 364015560 501(c)(3) 10600 CANCER SCREENING St Elizabeth Medical Center Inc 1 Medical Village Drive Edgewood KY 41017 610445850 501(c)(3) 16200 CANCER SCREENING 10 0 Advance Training 5 24384 Geraldine Colby Zeiler Award for Students of Cytotechnology 5 5000 Herbek Humanitarian Award 1 1500 Leadership Development Travel Award 23 21490 Keitges Grant for Medical Ethics 1 4400 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds WHEN NOTIFYING APPLICANTS OF AN AWARD, THE FOLLOWING OCCURS. 1. AWARD ANNOUNCEMENTS ARE SENT BY EMAIL TO AWARDEES. DEPENDING ON THE GRANT/AWARD RECIPIENTS MAY BE REQUESTED TO PROVIDE A CONFIRMATION OF ACCEPTANCE AND START DATE (as applicable). THE EMAIL ALSO DETAILS THE EXPENSE REIMBURSEMENT PROCESS, AND EVALUATION REQUIREMENTS. 2. NON-AWARDESS ARE NOTIFIED BY EMAIL. 3.DOCUMENTATON INCLUDING NOTIFICATIONS, AWARD LETTERS AND REPORTING REQUIREMENTS ARE RETAINED FOR EACH APPLICANT. THE PAYMENT PROCESS IS AS FOLLOWS. 1.ADVANCE TRAINING: - AWARD GIVEN TO AN INDIVIDUAL. - CASH ADVANCES OF 50% ARE PROVIDED TO ASSIST WITH TRAVEL AND HOTEL EXPENSES. - AWARDEE MUST SUBMIT A W-9. - THE REMAINING 50% IS PAID AFTER AWARDEE SUBMITS EXPENSE REIMBURSEMENT FORM AND EVALUATION. 2. CONFERENCE TRAVEL: - AWARD GIVEN TO AN INDIVIDUAL. - AWARDEES MUST PAY FOR ALL EXPENSES UPFRONT. - AWARDEE IS THEN REIMBURSED AFTER SUBMITTING AN EXPENSE REIMBURSEMENT WITH APPROPRIATE RECEIPTS, AND AN EVALUATION. - A W-9 IS NOT REQUIRED FOR THESE REIMBURSEMENTS. 3.RESEARCH AWARDS: - AWARD GIVEN TO AN INDIVIDUAL OR THEIR INSTITUTION - TO ACTIVATE FUNDING, THE AWARDEE OR THEIR INSTITUTION MUST SUBMIT A W-9 BEFORE THE FIRST HALF OF FUNDING IS SENT. - A PAYMENT SCHEDULE IS INCLUDED IN THE AWARD LETTER DETAILING DUE DATES FOR REQUIRED REPORTS. 4. SEE, TEST & TREAT GRANT: - AWARD FUNDING WILL ONLY BE MADE TO A 501 (c) (3) ORGANIZATION. - ORGANIZATION MUST SUBMIT A W-9. - GRANTEE RECEIVES 50% OF THE AWARD UPON APPLICATION APPROVAL. (within 2 months of program start date) - STT OUTCOMES DATA IS REQUIRED 30 DAYS POST PROGRAM. Additional programs outcome data will also be requested at a 3 month and 6 month interval. - BALANCE OF FUNDS RELEASED AFTER DOCUMENTED PROGRAM COSTS RECEIVED. 5.GENE AND JEAN HERBEK HUMANITARIAN AWARD: - AWARD BESTOWED TO AN INDIVIDUAL. (recognition award) - AWARD IS PRESENTED AT THE CAP ANNUAL MEETING. AWARDEES MUST PAY FOR ALL EXPENSES UPFRONT. - AWARDEE IS THEN REIMBURSED AFTER SUBMITTING AN EXPENSE REIMBURSEMENT WITH APPROPRIATE RECEIPTS. - A W-9 IS NOT REQUIRED FOR THESE REIMBURSEMENTS. 6. SEE, TEST & TREAT OUTSTANDING PARTNER AWARD - AWARD BESTOWED TO AN INDIVIDUAL OR AN ORGANIZATION. (RECOGNITION AWARD) - AWARD IS PRESENTED AT THE RECIPIENTS HOME INSTITUTION false false false false false false false MICHAEL FRASER CAP CEO DIRECTOR (Start 03/2024) 0 484941 0 0 0 76957 0 0 0 3520 0 565418 0 0 STEPHEN R MYERS CAP CEO DIRECTOR (THRU 03/2024) 0 283345 0 288379 0 1322 0 28670 0 9479 0 611195 0 0 MAYA OGDEN EXECUTIVE DIRECTOR CAP FOUNDATION 0 167583 0 29450 0 155 0 17455 0 28175 0 242818 0 0 JULIA RANKENBURG PROGRAM DEVELOPMENT MANAGER 0 125971 0 10369 0 696 0 13603 0 31141 0 181780 0 0 Schedule J, Part I, Line 3 Arrangement used to establish the top management official's compensation FOUNDATION EMPLOYEES ARE COMPENSATED DIRECTLY BY THE COLLEGE OF AMERICAN PATHOLOGISTS (CAP), A RELATED ORGANIZATION. THEREFORE, ALL COMPENSATION IS ESTABLISHED BY THE CAP. THE EXECUTIVE DIRECTOR'S COMPENSATION WAS SET BASED ON MARKET DATA SPECIFICALLY FOR THOSE POSITIONS WITH SIMILAR SCOPE OF RESPONSIBILITIES. THE POSITION WAS THEN REVIEWED AND INCORPORATED INTO THE CAP'S SALARY STRUCTURE AT THE GRADE WHERE THE 50TH PERCENTILE OF MARKET DATA WAS MOST CLOSELY ALIGNED WITH MIDPOINT. THE INCUMBENT'S SALARY WAS SET WITHIN THE APPROPRIATE GRADE BASED ON THE INCUMBENT'S SKILLS AND IS MANAGED BASED ON PERFORMANCE. Schedule J, Part II, Column (B) AMOUNT INCLUDES INCENTIVE EARNED IN 2023 AND PAID IN 2024. Form 990, Part III, Line 1 OUR MISSION IS TO IMPROVE PEOPLE'S HEALTH BY: - DEVELOPING TOMORROW'S PATHOLOGY LEADERS THROUGH AWARDS FOR ADVANCED TRAINING, RESEARCH, AND EDUCATION. - MOBILIZING PATHOLOGISTS TO EXPAND HEALTH EQUITY IN MEDICALLY UNDERSERVED COMMUNITIES WITHIN THE US AND GLOBALLY. OUR VISION IS THAT PATHOLOGISTS ARE EQUIPPED TO BRIDGE HEALTH DISPARITIES AND ENHANCE OUTCOMES GLOBALLY. Form 990, Part VI, Line 15a PROCESS FOR DETERMINING COMP FOR CEO THE FOUNDATION DOES NOT PAY THE SALARIES OF THE FOUNDATION EMPLOYEES DIRECTLY. INSTEAD, THE FOUNDATION REIMBURSES THE CAP FOR PERSONNEL ON A QUARTERLY BASIS. COMPENSATION OF THE CAP'S CHIEF EXECUTIVE OFFICER IS NOT CHARGED TO THE FOUNDATION. THE TERMS OF THE CAP CHIEF EXECUTIVE OFFICER'S COMPENSATION ARE DETAILED IN THE EMPLOYMENT AGREEMENT AND ADMINISTERED IN KEEPING WITH THE RELATED CAP BOARD-APPROVED EXECUTIVE COMPENSATION PHILOSOPHY AND STRATEGY. COMPENSATION OF THE FOUNDATION'S EXECUTIVE DIRECTOR IS CHARGED TO THE FOUNDATION. EXECUTIVE COMPENSATION THE ORGANIZATION DESIRES TO ENSURE THAT ITS EXECUTIVE COMPENSATION PROGRAM IS COMPETITIVE, FAIR, AND EQUITABLE, AS WELL AS COMPLIANT WITH REGULATORY GUIDELINES AND REPRESENTATIVE OF MARKET BEST PRACTICES. THE ORGANIZATION WILL CONSIDER NATIONAL PEER GROUPS OF ORGANIZATIONS COMPARABLE IN SIZE (I.E. REVENUE) AND COMPLEXITY TO DETERMINE THE MARKET VALUES FOR EACH OF ITS EXECUTIVE POSITIONS. THESE PEER GROUPS VARY BY POSITION AND REQUIRED SKILL SETS. MARKET COMPARATORS FROM SELECT TAX EXEMPT AND FOR-PROFIT ORGANIZATIONS PROVIDE A SECONDARY BENCHMARK. THE CAP HAS ESTABLISHED A TARGET POSITION FOR EACH OF THE FOLLOWING COMPONENTS OF ITS EXECUTIVE TOTAL COMPENSATION PROGRAM: BASE SALARIES, TOTAL CASH COMPENSATION, TOTAL DIRECT COMPENSATION, QUALIFIED BENEFITS, SUPPLEMENTAL BENEFITS AND PERQUISITES, AND SEVERANCE. THE ORGANIZATION WILL EXERCISE THE UTMOST CARE IN ENSURING THAT ALL ELEMENTS OF EACH EXECUTIVE COMPENSATION IS PROPERLY REPORTED AS REQUIRED ON INTERNAL REVENUE SERVICE FORMS W-2, 941, AND 990. Form 990, Part VI, Line 11b Review of form 990 by governing body DURING THE PREPARATION OF THE FORM 990, THE COLLEGE OF AMERICAN PATHOLOGISTS FOUNDATION'S (FOUNDATION) EXECUTIVE DIRECTOR IS CONSULTED FOR INFORMATION NEEDED FOR THE TAX YEAR. THE FORM 990 IS REVIEWED BY THE COLLEGE OF AMERICAN PATHOLOGIST (CAP) CHIEF OPERATING OFFICER. THE FINAL FORM 990 IS SHARED WITH THE FOUNDATION'S ENTIRE BOARD. Form 990, Part VI, Line 12c Conflict of interest policy THE FOUNDATION'S EXECUTIVE DIRECTOR/GOVERNANCE COMMITTEE PROVIDES A CONFLICT-OF-INTEREST DISCLOSURE FORM TO ALL FOUNDATION BOARD MEMBERS AND THE EXECUTIVE DIRECTOR AT THE BEGINNING OF THE YEAR. WHEN DISCLOSURE FORMS ARE COLLECTED, NOTED CONFLICTS ARE REVIEWED. ACTION IS TAKEN TO ADDRESS THE DISCLOSED CONFLICTS; THE SPECIFIC ACTIONS ARE SHARED WITH THE FOUNDATION'S EXECUTIVE COMMITTEE. IF THE EXECUTIVE DIRECTOR/GOVERNANCE COMMITTEE DEEMS CORRECTIVE ACTION IS NECESSARY, THE CONFLICT IS ADDRESSED WITH THE FOUNDATION BOARD. Form 990, Part VI, Line 19 Required documents available to the public THE FOUNDATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ANNUAL AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON THE ILLINOIS ATTORNEY GENERAL'S WEBSITE. COLLEGE OF AMERICAN PATHOLOGISTS 325 WAUKEGAN ROAD NORTHFIELD IL 600932750 362118323 See Part VII IL 501(c)(6) NA false false false true false false false false false false false true false true true true true false false false COLLEGE OF AMERICAN PATHOLOGISTS FUNDATION C 500000 CASH COLLEGE OF AMERICAN PATHOLOGISTS FUNDATION O 733694 COST COLLEGE OF AMERICAN PATHOLOGISTS FUNDATION P 202985 COST Schedule R, Part II, Column (b) THE CAP'S PRIMARY ACTIVITY IS TO FOSTER THE HIGHEST STANDARDS IN EDUCATION, RESEARCH, AND THE PRACTICE OF PATHOLOGY; TO ADVANCE THE SCIENCE OF PATHOLOGY, AND IMPROVE MEDICAL LABORATORY SERVICE TO PATIENTS, PHYSICIANS, HOSPITALS, AND THE PUBLIC; AND TO ENHANCE THE DIGNITY, SCIENTIFIC COMPETENCE, AND EFFICIENT PRACTICE OF THE SPECIALTY OF PATHOLOGY FOR SERVICE OF THE COMMON GOOD.